Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.

Literature DB >> 776199

Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.

R R Joseph, D Belpomme, G Mathé.

Abstract

Entities: Disease

Mesh：

Substances：
BCG Vaccine

Year: 1976 PMID： 776199 PMCID： PMC2024950 DOI： 10.1038/bjc.1976.91

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

12 in total

1. The role of the reticuloendothelial system in the host reaction to neoplasia.

Authors: L J OLD; B BENACERRAF; D A CLARKE; E A CARSWELL; E STOCKERT
Journal: Cancer Res Date: 1961-10 Impact factor: 12.701

2. T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia.

Authors: D Belpomme; D Dantchev; E Du Rusquec; D Grandjon; R Huchet; P Pouillart; L Schwarzenberg; J L Amiel; G Mathé
Journal: Biomedicine Date: 1974-03

3. Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.

Authors: A H Greenberg; L Hudson; L Shen; I M Roitt
Journal: Nat New Biol Date: 1973-03-28

4. Rosette-forming T cells in human peripheral blood at different ages.

Authors: E D Carosella; K Mochanko; M Braun
Journal: Cell Immunol Date: 1974-05 Impact factor: 4.868

5. Active immunotherapy for acute lymphoblastic leukaemia.

Authors: G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal: Lancet Date: 1969-04-05 Impact factor: 79.321

6. Editorial: How clinically useful is T and B cell quantitation?

Authors: J Wybran; H Fudenberg
Journal: Ann Intern Med Date: 1974-06 Impact factor: 25.391

7. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.

Authors: G Mathé; M Kamel; M Dezfulian; O Halle-Pannenko; C Bourut
Journal: Cancer Res Date: 1973-09 Impact factor: 12.701

Review 8. Immunochemotherapy of human cancer.

Authors: J U Gutterman; G M Mavligit; R C Reed; E M Hersh
Journal: Semin Oncol Date: 1974-12 Impact factor: 4.929

Increase in "Null" cells in acute lymphocytic leukaemia in remission on long-term immunotherapy.

1. The role of the reticuloendothelial system in the host reaction to neoplasia.

2. T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia.

3. Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.

4. Rosette-forming T cells in human peripheral blood at different ages.

5. Active immunotherapy for acute lymphoblastic leukaemia.

6. Editorial: How clinically useful is T and B cell quantitation?

7. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.

Review 8. Immunochemotherapy of human cancer.

Review 9. Use of BCG in the treatment of human neoplasms: a review.

10. Impaired lymphocyte function in aged humans.

1. Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations.

2. Chemotherapy, a double agent in respect of immune functions.